γ-Secretase regulates VEGFR-1 signalling in vascular endothelium and rpe

Advances in Experimental Medicine and Biology

Volumn 613, Issue , 2008, Pages 313-319

  Boulton, Michael E ^a   Cai, Jun ^b   Grant, Maria B ^b   Zhang, Yadan ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE; PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; ISOPROTEIN; LIGAND; SECRETASE;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; ENDOTHELIUM CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR BINDING; RETINA CELL; VASCULAR ENDOTHELIUM; ANIMAL; CAPILLARY PERMEABILITY; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYDROLYSIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROLYSIS; LIGANDS; NEOVASCULARIZATION, PATHOLOGIC; PIGMENT EPITHELIUM OF EYE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 38949206637     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74904-4_36     Document Type: Conference Paper

References (31)

1. Autiero, M., et al., 2003. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 9, 936-43.
2. Bussolati, B., et al., 2001. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol. 159, 993-1008.
3. Cai, J., Boulton, M., 2002. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 16, 242-60.
4. Cai, J., et al., 2006. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem. 281, 3604-13.
5. Ferrara, N., 2005. The role of VEGF in the regulation of physiological and pathological angiogenesis. Exs. 209-31.
6. Grant, M. B., et al., 2004. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs. 13, 1275-93.
7. Hellstrom, M., et al., 2007. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 445, 776-80.
8. Hiratsuka, S., et al., 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 95, 9349-54.
9. Kanning, K. C., et al., 2003. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J Neurosci. 23, 5425-36.
10. Landman, N., Kim, T. W., 2004. Got RIP? Presenilin-dependent intramembrane proteolysis in growth factor receptor signaling. Cytokine Growth Factor Rev. 15, 337-51.
11. Lee, P., et al., 1998. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 43, 245-69.
12. Luttun, A., et al., 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 8, 831-40.
13. Marambaud, P., et al., 2002. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. Embo J. 21, 1948-56.
14. Mastrangelo, P., et al., 2005. Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases. Proc Natl Acad Sci U S A. 102, 8972-7.
15. Murakami, Y., et al., 2006. Ets-1-dependent Expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's Sarcoma-associated herpesvirus through interaction with daxx. J Biol Chem. 281, 28113-21.
16. Nakajima, M., et al., 2006. Presenilin-1 controls the growth and differentiation of endothelial progenitor cells through its beta-catenin-binding region. Cell Biol Int. 30, 239-43.
17. Nakajima,M., et al., 2003. Abnormal blood vessel development in mice lacking presenilin-1. Mech Dev. 120, 657-67.
18. Ni, C. Y., et al., 2001. gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science. 294, 2179-81.
19. Nozaki, M., et al., 2006. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest. 116, 422-9.
20. Rahimi, N., 2006. VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. Front. Biosci. 11, 818-829.
21. Rahimi, N., et al., 2000. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem. 275, 16986-92.
22. Rawson, R. B., 2002. Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus. Essays Biochem. 38, 155-68.
23. Roberts, D. M., et al., 2004. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol. 164, 1531-5.
24. Sainson, R. C., et al., 2005. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. Faseb J. 19, 1027-29.
25. Selkoe, D., Kopan, R., 2003. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 26, 565-97.
26. Shen, J., et al., 2006. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther. 13, 225-34.
27. Shibuya, M., Claesson-Welsh, L., 2006. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 312, 549-60.
28. vanWijngaarden, P., et al., 2005. Inhibitors of ocular neovascularization: promises and potential problems. Jama. 293, 1509-13.
29. Witmer, A. N., et al., 2003. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 22, 1-29.
30. Wolfe, M. S., 2006. The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry. 45, 7931-39.
31. Zeng, H., et al., 2001. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 276, 26969-79.